Navigation Links
Labopharm Reports Results for Third Quarter Fiscal 2007
Date:11/9/2007

d from the corresponding quarter of fiscal 2006 at $0.8 million.

Selling, general and administrative expenses for the third quarter of fiscal 2007 increased to $4.6 million from $4.1 million for the third quarter of fiscal 2006. The increase is due primarily to increased headcount and related compensation expense and increased sales and marketing and other operational costs as the Company transitions from a research and development company to a commercial operation.

At September 30, 2007, the Company held investments in Canadian third party asset-backed commercial paper (ABCP) with an original cost of $5.6 million. When acquired, these investments were rated R1 (High) by Dominion Bond Rating service (DBRS), the highest credit rating issued for commercial paper. These investments matured in October 2007 but, as a result of liquidity issues in the ABCP market, did not settle on maturity. As a result, the Company has adjusted the estimated fair value of the investment and taken a charge in the third quarter of $0.9 million and classified its ABCP as a long-term investment.

Net loss for the third quarter of fiscal 2007 was $9.0 million, or $0.16 per share, compared with $4.4 million, or $0.08 per share, for the third quarter of fiscal 2006.

Cash, cash equivalents and marketable securities at September 30, 2007 were $68.4 million ($73.3 million including the ABCP that was classified as a long-term investment) compared with $99.5 million at December 31, 2007. Excluding the reclassification and write down of the ABCP discussed above, Labopharm's cash, cash equivalents and marketable securities decreased $25.3 million compared to December 31, 2007. This decrease was primarily the result of the use of funds for operating activities.

For the nine-month period ended September 30, 2007, revenue increased to $16.3 million from $10.7 million for the first nine months of 2006. Product sales increased to $10.4 million from $4.0 million, primarily the r
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... The American Society of Hematology (ASH) and S... education, and media company, are launching &ldqu...cience curriculum designed to spark interest in th...xposing students to exciting career opportunities ...on (PRWEB) November 25, 2009 -- The American Socie...
(Date:11/25/2009)...r25/PRNewswire/--Therearemanywaysyoucanimprove,you...utthere,alwaysseemstobeconflictingadviceconcerning.... , So,therealbuzz.comteamhascompiledalistof2...ncontrovertible!Doingacombinationof,oursuggestedac...,andwell-being-sotrythemout. , 1.Reduceyourfa...
(Date:11/24/2009)...s of salt is linked to a significantly higher risk...aper published today in the British Medical Journ...he World Health Organization,s Collaborating Centr...k and University Hospital in Coventry, UK, and the...e in Hypertension based at the Department of Clini...
(Date:11/24/2009)...S,Mich.,Nov.24/PRNewswire/--SkyFoundation,Inc.,ano...researchtodevelopabloodtestfortheearlydetectionofp...100,000sinceitsinceptioninJune2008.Theannouncement...aftertheorganization,sfirstmajorfundraiser. ,, ...8,atabrunchatTheVillageClubinBloomfieldHills,Mich....
(Date:11/24/2009).../PRNewswire/-- Asyear-endapproaches,manyemployees...arandnext.Tohelpyoutakeadvantageofthesespecialtax-...statThomsonReuters,highlightsthefollowingkeyyear-e...thflexiblespendingaccounts(HealthFSAs) . Manyemp...esbyplacingfundsintheiremployer,shealthFSA.Theseem...
Breaking Medicine News(10 mins):Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:High salt intake linked to strokes and cardiovascular disease 2Health News:Sky Foundation, Inc. Raises More Than $100,000 to Find a Test for Early Detection of Pancreatic Cancer 2Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3
...tion,(Nasdaq: CRVL ) reported record earnings per... 2007, up 61% from the $0.27 earnings per share re...cember 2007 quarter revenues,were $76.7 million, u...s in all product lines, as well as the current,Ent...
...ect,President Bush,s Fiscal Year 2009 budget in or...er 1.1 million people living with HIV/AIDS in the,...ive Director of The AIDS,Institute. "Most of the p...he world, we can,t turn our backs on them. The,bud...
...al is,celebrating its second anniversary. Gilbert,...s since treated more than 93,000 patients and has ...t to the community by,guaranteeing emergency room ...e. "There is simply no excuse for patients,to wait...
...ting firm,dedicated exclusively to improving the p...s opportunities for payors, announces the recent,i...proprietary auditing,system., Auditing is a criti...hich errors can occur. Fraud, hierarchical,benefit...
...otection Agency has given $97,204 to the Ohio Depa...and women of child-bearing age on,environmental he...0 in,similar grants nationwide. In Ohio, the grant...ental health issues that could,affect women and th...
... Nursing Workforce Development,Programs will stifl...e-level nurses and faculty, WASHINGTON, Feb. 4 T...ing (AACN) expressed its concern that,proposed cut... the nation,s nursing shortage. Despite the propos...
Other Medicine News:Health News:CorVel Announces Record Earnings Per Share 2Health News:CorVel Announces Record Earnings Per Share 3Health News:CorVel Announces Record Earnings Per Share 4Health News:CorVel Announces Record Earnings Per Share 5Health News:President's FY09 Budget - A Disaster for Domestic AIDS: Congress Must Fund Critical Healthcare Priorities 2Health News:President's FY09 Budget - A Disaster for Domestic AIDS: Congress Must Fund Critical Healthcare Priorities 3Health News:Gilbert Hospital Turns Two 2Health News:ARMSRx Tackles the New Rx Addiction -- Pharmacy Benefit Audits 2Health News:AACN Concerned That the President's FY 2009 Budget Request Will Prolong the Nursing and Nurse Faculty Shortage 2Health News:AACN Concerned That the President's FY 2009 Budget Request Will Prolong the Nursing and Nurse Faculty Shortage 3
(Date:11/24/2009)...,, NORTHHOLLYWOOD,Calif.,Nov.24/PRNewswire-Fi...CM ),aleadingnationalhospitalistphysiciangroupprac...ACP,anIPChospitalist,wasnamedby ACPHospitalist aso...gnizedintheNovember2009issueofthemagazine. ,, D...earsandcurrentlyservesasdirectorofhospitalmedicine...
(Date:11/24/2009)...,, MOUNTAINVIEW,Calif.,Nov.24/PRNewswire/--Sa...rovidersofkidneydialysisservicesandamajorsponsorof...enalDiseasesurvivorandchefEliasNasrallahinhiseffor...y. ,, EliasNasrallahbuiltasuccessfulcareerasach...ide-downfiveyearsago,whenhewasdiagnosedwithEndStag...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--Opt...topresentatthe21stAnnualPiperJaffrayHealthCareConf...009at1:00p.m.EasternTime. ,, (Logo: http://www...., Aliveaudiowebcastofthispresentationwillbeacces...w.optimerpharma.com .Replaysofthispresentationwil...
Breaking Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 1Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 4Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 1Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 2Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3
...ems Incorporated,(Nasdaq: IMCL ) and Bristol-Myer...t the U.S. Food and Drug Administration (FDA) has ...roduct labeling to include overall survival,data a...tor,(EGFR)-expressing metastatic colorectal cancer... and oxaliplatin-based regimens. The approval of ...
...tudies have suggested that,moderate red wine consu...,what if you,d like to skip the alcohol? Take hear...EALTH 2007 conference in Bordeaux, France,showed t...axation effect in,a similar fashion to red wine. T...rd grape juice induced a prolonged relaxation effe...
Other Medicine Technology:Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine 2
Ishihara Test 38 Plate Book
MVR Blades
...fe. 1.1 mm (19G) with a 1.38 mm width for insertio...f-the-art manufacturing and quality control ensure...ure grip handles have a ridge indicating position ... incision for self-sealing wounds. Gauge size is o...
Lens Plus Daily Cleaner
Medicine Products: